Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 21, 2009; 15(19): 2367-2371
Published online May 21, 2009. doi: 10.3748/wjg.15.2367
Table 1 Demographic and clinical data (n = 29)
Clinical parametern(%) or mean ± SD
Age
mean ± SD (yr)64.5 ± 16.8
Range24-86
Sex
Men13 (44.8)
Women16 (55.2)
Main indication for ERC
Cholestasis/jaundice16 (55.2)
Choledocholithiasis/dilated CBD5 (17.2)
Cholangitis3 (10.3)
SOL of papilla3 (10.3)
Unresolved pancreatitis2 (6.9)
Abdominal ultrasound results
Dilated CBD15 (51.7)
Cholelithiasis12 (41.4)
Dilated intrahepatic ducts10 (34.5)
Choledocholithiasis3 (10.3)
Pancreatitis1 (3.4)
CBD width (mm)
mean ± SD8.7 ± 3.7
Range6-18
Liver function tests, mean ± SD (range)
Total bilirubin (mg/dL)4.5 ± 6.9 (0.3-32)
Direct bilirubin (mg/dL)3.0 ± 4.9 (0.1-23)
Alanine aminotransferase (U/L)206.5 ± 243.3 (12-895)
Aspartate aminotransferase (U/L)156.4 ± 185.6 (15-812)
Gamma glutamyl transpeptidase (U/L)369.4 ± 370.4 (13-1337)
Alkaline phosphatase (U/L)291.0 ± 371.4 (56-1893)
Table 2 Results of ERC (n = 29)
Clinical parametern(%) or mean ± SD
Diagnosis
CBD width (mm)9.4 ± 4.0
Range6-18
Choledocholithiasis11 (37.9)
Pigmented stones4 (13.8)
Cholelithiasis5 (17.2)
Enlarged papilla7 (24.1)
Dilated CBD15 (51.7)
CBD stricture4 (13.8)
Intrahepatic ducts dilation & stricture3 (10.3)
Torn papilla3 (10.3)
Bile leakage1 (3.4)
Mirizzi syndrome1 (3.4)
Treatment
Sphincterotomy16 (55.2)
Biopsy of the papilla5 (17.2)
Stent insertion2 (6.9)
Cholecystostomy1 (3.4)
Table 3 Mucin gene expression in bile collected in ERC
Mucin geneScore mean ± SD (range)Cases (%)
MUC10.62 ± 0.94 (0-3)34.4
MUC20.58 ± 0.90 (0-3)34.4
MUC30.79 ± 0.97 (0-3)51.7
MUC5AC1.06 ± 1.22 (0-3)51.7
MUC5B1.20 ± 1.26 (0-3)55.1
MUC60.41 ± 0.73 (0-2)27.5
Table 4 Correlation between the expression of the different mucin genes in bile collected by ERC
Mucin geneCorrelation with mucin genePvalue
MUC1MUC20.0001
MUC30.0001
MUC5AC0.0125
MUC5B0.049
MUC60.0001
MUC2MUC30.0001
MUC5AC0.0080
MUC5B0.0001
MUC60.0001
MUC3MUC5AC0.0031
MUC60.0003
Table 5 Comparison between patients with (n = 17) and without (n = 12) gallstones
Gallstones diseas n (%)No evidence for gallstones n (%)Pvalue
Age, mean ± SD (years)61.35 ± 20.1369.00 ± 9.580.234
Sex (men)8 (47.1)5 (41.7)0.927
Main indication for ERC
Jaundice7 (41.1)9 (75)0.153
Dilated CBD4 (23.5)1 (8.0)0.554
Cholangitis3 (20.0)00.288
SOL of papilla1 (6.0)2 (17.0)0.737
Unresolved pancreatitis2 (12.0)00.288
Abdominal ultrasound results
Dilated CBD10 (59.0)5 (42)0.599
Cholelithiasis12 (70.6)0< 0.0001
Dilated intrahepatic ducts6 (40)4 (30)0.873
Choledocholithiasis3 (17.6)00.360
Pancreatitis1 (5.9)00.861
CBD width (mm), mean ± SD9.65 ± 4.397.50 ± 2.240.132
Liver function tests, mean ± SD
Total bilirubin (mg/dL)5.12 ± 7.833.68 ± 5.520.589
Direct bilirubin (mg/dL)3.38 ± 5.532.55 ± 4.030.662
Alanine aminotransferase (U/L)245.41 ± 270.76151.58 ± 196.140.315
Aspartate aminotransferase (U/L)167.29 ± 150.54141.08 ± 233.110.715
Gamma glutamyl transpeptidase (U/L)443.47 ± 388.13264.50 ± 331.140.206
Alkaline phosphatase (U/L)352.88 ± 449.95185.08 ± 174.440.323
ERC diagnosis
CBD width (mm), mean ± SD9.59 ± 3.999.17 ± 4.370.790
Choledocholithiasis11 (64.7)00.002
Pigmented stones4 (24.0)00.198
Cholelithiasis5 (29.0)00.122
Enlarged papilla3 (16.0)4 (33.0)0.533
Dilated CBD10 (60.0)5 (40.0)0.494
CBD stricture1 (10.0)3 (30.0)0.376
Torn papilla3 (17.6)00.360
Treatment
Sphincterotomy12 (71.0)4 (33.0)0.099
Biopsy of the papilla1 (10.0)4 (33.0)0.288
Mucin gene score, mean ± SD
Mucin concentration (mg/mL)21.68 ± 7.8724.54 ± 24.10.759
Protein concentration (mg/mL)7.87 ± 4.538.61 ± 5.480.694
MUC10.59 ± 0.870.66 ± 1.070.848
MUC20.53 ± 0.800.66 ± 1.070.711
MUC30.88 ± 0.930.66 ± 1.070.560
MUC5AC0.47 ± 0.800.33 ± 0.650.621
MUC5B1.23 ± 1.250.83 ± 1.190.394
MUC61.29 ± 1.261.08 ± 1.310.667